Incidence, Predictors and Outcomes Related to Hypo and Hyperkalemia in Severe Heart Failure Patients Treated With an Aldosterone Antagonist

被引：2
|
作者：
Vardeny, Orly [1 ]
Wu, DongHong [2 ]
Claggett, Brian [2 ]
Desai, Akshay [2 ]
Rossignol, Patrick [3 ,4 ]
Zannad, Faiez [5 ]
Pitt, Bertram
Solomon, Scott D. [2 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] INSERM, Ctr Invest Clin 9501, Nancy, France
[4] Nancy Univ, Nancy, France
[5] Univ Michigan, Sch Med, Ann Arbor, MI USA
来源：
JOURNAL OF CARDIAC FAILURE | 2012年 / 18卷 / 08期
关键词：
D O I：
10.1016/j.cardfail.2012.06.193
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
181
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [1] Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist
    Vardeny, Orly
    Claggett, Brian
    Anand, Inder
    Rossignol, Patrick
    Desai, Akshay S.
    Zannad, Faiez
    Pitt, Bertram
    Solomon, Scott D.
    CIRCULATION-HEART FAILURE, 2014, 7 (04) : 573 - 579
  • [2] Incidence and predictors of hyperkalemia in patients with heart failure
    Desai, Akshay S.
    Swedberg, Karl
    McMurray, John V.
    Granger, Christopher B.
    Yusuf, Salim
    Young, James B.
    Dunlap, Mark E.
    Solomon, Scott D.
    Hainer, James W.
    Olofsson, Bertil
    Michelson, Eric L.
    Pfeffer, Marc A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (20) : 1959 - 1966
  • [3] EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE
    CARRUTHERS, BM
    WALSH, GC
    BAIRD, MM
    SERAGLIA, M
    MCINTOSH, HW
    LEDRAY, RD
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1963, 89 (13) : 633 - &
  • [4] Incidence Rate of Hyperkalemia-related Hospitalization After Initiation of a Mineralocorticoid Receptor Antagonist in Patients with Heart Failure
    Chauhan, Vishal R.
    Dev, Sandesh
    Pham, Michael
    Lin, Shoutz
    Heidenreich, Paul
    CIRCULATION, 2014, 130
  • [5] PLASMA ALDOSTERONE LEVELS IN PATIENTS WITH SEVERE, TREATED HEART-FAILURE
    HAMER, J
    KNIGHT, R
    MIALL, P
    HAWKINS, LA
    DACOMBE, J
    BRITISH HEART JOURNAL, 1976, 38 (05): : 534 - 534
  • [6] Hyperkalemia in patients with heart failure: Incidence, prevalence, and management
    Desai A.S.
    Current Heart Failure Reports, 2009, 6 (4) : 272 - 280
  • [7] Incidence and predictors of hyperkalemia in patients with heart failure - An analysis of the candesartan in heart failure - Assessment of reduction in mortality and morbidity (CHARM) program
    Desai, AS
    Swedberg, K
    Mcmurray, JJV
    Granger, CB
    Yusut, S
    Young, JB
    Dunlap, ME
    Solomon, SD
    Hainer, JW
    Olotsson, B
    Michelson, EL
    Pfeffer, MA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 52A - 52A
  • [8] Development Of An Electronic Health Record-based Prediction Model For Hyperkalemia And Clinical Outcomes In Aldosterone Receptor Antagonist-prescribed Heart Failure Patients
    Dumeny, Leanne
    McDonough, Caitrin W.
    Duarte, Julio
    Cavallari, Larisa H.
    CIRCULATION, 2022, 145
  • [9] Mineralcorticoid Receptor Antagonist Withdrawal for Hyperkalemia and Mortality in Patients with Heart Failure
    Lisi, Francesco
    Parisi, Giuseppe
    Gioia, Margherita Ilaria
    Amato, Luca
    Bellino, Maria Consiglia
    Grande, Dario
    Massari, Francesco
    Caldarola, Pasquale
    Ciccone, Marco Matteo
    Iacoviello, Massimo
    CARDIORENAL MEDICINE, 2020, 10 (03) : 145 - 153
  • [10] MINERALCORTICOID RECEPTOR ANTAGONIST WITHDRAWAL FOR HYPERKALEMIA AND MORTALITY IN PATIENTS WITH HEART FAILURE
    Lisi, F.
    Parisi, G.
    Gioia, M.
    Amato, L.
    Bellino, M.
    Grande, D.
    Ciccone, M.
    Caldarola, P.
    Iacoviello, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G25 - G26
12345